IVS Faculty Publications on Vaccine Safety

2020

  • Gostin LO, Salmon DA. The Dual Epidemics of COVID-19 and Influenza: Vaccine Acceptance, Coverage, and Mandates. JAMA. Published online June 11, 2020. doi:10.1001/jama.2020.10802 PubMed Abstract.
  • Carol Liu YC, Ibekwe T, Kelso JM, Klein NP, Shehu N, Steuerwald, Aneja S, Dudley MZ, Garry R, Munoz FM, The Brighton Collaboration SNHL Working Group. Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine.2020;S0264-410X(20)30637-X. doi:10.1016/j.vaccine.2020.05.019. PubMed Abstract.
  • Limaye RJ, Malik F, Frew PM, Randall LA, Ellingson MK, O’Leary ST, Bednarczyk RA, Oloko O, Salmon DA, Omer SB. Patient Decision Making Related to Maternal and Childhood Vaccines: Exploring the Role of Trust in Providers Through a Relational Theory of Power Approach. Health Educ Behav. 2020 Apr 20:1090198120915432. doi: 10.1177/1090198120915432. PubMed Abstract.
  • Dudley MZHalsey NA, Omer SB, Orenstein WA, O’Leary ST, Limaye RJSalmon DA. The state of vaccine safety science: systematic reviews of the evidence. Lancet Infect Dis. 2020 Apr 9. pii: S1473-3099(20)30130-4. doi: 10.1016/S1473-3099(20)30130-4. [Epub ahead of print] Review. PubMed Abstract.
  • Dudley MZLimaye RJ, Omer SB, O’Leary ST, Ellingson MK, Spina CI, Brewer SE, Chamberlain AT, Bednarczyk RA, Malik F, Frew PM, Salmon DA. Factors associated with referring close contacts to an app with individually-tailored vaccine information. Vaccine. 2020 Mar 17;38(13):2827-2832. doi: 10.1016/j.vaccine.2020.02.019. Epub 2020 Feb 22. PubMed Abstract.
  • Christianson MS, Wodi P, Talaat KHalsey N. Primary ovarian insufficiency and human papilloma virus vaccines: a review of the current evidence. Am J Obstet Gynecol. 2020 Mar;222(3):239-244. doi: 10.1016/j.ajog.2019.08.045. Epub 2019 Aug 31. PubMed Abstract.
  • Holroyd TA, Oloko OK, Salmon DA, Omer SB, Limaye RJ. Communicating Recommendations in Public Health Emergencies: The Role of Public Health Authorities. Health Secur. 2020 Jan/Feb;18(1):21-28. doi: 10.1089/hs.2019.0073. PubMed Abstract.
  • Dudley MZLimaye RJ, Omer SB, O’Leary ST, Ellingson MK, Spina CI, Brewer SE, Chamberlain AT, Bednarczyk RA, Malik F, Frew PM, Salmon DA. Characterizing the vaccine knowledge, attitudes, beliefs, and intentions of pregnant women in Georgia and Colorado. Hum Vaccin Immunother. 2020 Feb 20:1-9. doi: 10.1080/21645515.2020.1717130. [Epub ahead of print] PubMed Abstract.
  • Dudley MZ, Privor-Dumm L, Dubé È, MacDonald NE. Words matter: Vaccine hesitancy, vaccine demand, vaccine confidence, herd immunity and mandatory vaccination. Vaccine. 2020 Jan 22;38(4):709-711. doi: 10.1016/j.vaccine.2019.11.056. Epub 2019 Dec 11. PubMed Abstract.

2019

  • Talaat KR, Bourgeois AL, Frenck RW, Chen WH, MacLennan CA, Riddle MS, Suvarnapunya AE, Brubaker JL, Kotloff KL, Porter CK. Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies. Clin Infect Dis. 2019 Dec 9;69(Supplement_8):S580-S590. doi: 10.1093/cid/ciz892. PubMed Abstract.
  • MacLennan CA, Riddle MS, Chen WH, Talaat KR, Jain V, Bourgeois AL, Frenck R, Kotloff K, Porter CK. Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints. Clin Infect Dis. 2019 Dec 9;69(Supplement_8):S591-S595. doi: 10.1093/cid/ciz891. PubMed Abstract.
  • Delamater PL, Buttenheim AM, Klein NP, Mohanty S, Salmon DA, Omer SB. Assessment of Exemptions From Vaccination in California, 2015 to 2027. Ann Intern Med. 2019 Nov 5. doi: 10.7326/M19-1933. [Epub ahead of print] PubMed Abstract.
  • Salmon DALimaye RJDudley MZ, Oloko OK, Church-Balin C, Ellingson MK, Spina CI, Brewer SE, Orenstein WA, Halsey NA, Chamberlain AT, Bednarczyk RA, Malik FA, Frew PM, O’Leary ST, Omer SB. MomsTalkShots: An individually tailored educational application for maternal and infant vaccines. Vaccine. 2019 Oct 8;37(43):6478-6485. doi: 10.1016/j.vaccine.2019.08.080. Epub 2019 Sep 7. PubMed Abstract.
  • Limaye RJ, Sara AB, Siddique AR, Vivas C, Malik S, Omonoju K. Interpersonal and community influences affecting childhood vaccination decision-making among Nigerian caregivers: Perceptions among frontline workers in Nigeria. J Child Health Care. 2019 Sep;23(3):403-414. doi: 10.1177/1367493519852457. Epub 2019 May 23. PubMed Abstract.
  • Hanevik K, Chen WH, Talaat KR, Porter C, Bourgeois L. The way forward for ETEC controlled human infection models (CHIMs). Vaccine. 2019 Aug 7;37(34):4794-4799. doi: 10.1016/j.vaccine.2019.01.003. Epub 2019 Jan 29. PubMed Abstract.
  • Bernstein J, Holroyd TA, Atwell JE, Ali J, Limaye RJ. Rockland county’s proposed ban against unvaccinated minors: Balancing disease control, trust, and liberty. Vaccine. 2019 Jul 9;37(30):3933-3935. doi: 10.1016/j.vaccine.2019.05.093. Epub 2019 Jun 10. PubMed Abstract.
  • Pingali SC, Delamater PL, Buttenheim AM, Salmon DA, Klein NP, Omer SB. Associations of Statewide Legislative and Administrative Interventions With Vaccination Status Among Kindergartners in California. JAMA. 2019 Jul 2;322(1):49-56. doi: 10.1001/jama.2019.7924. PubMed Abstract.
  • Delamater PL, Pingali SC, Buttenheim AM, Salmon DA, Klein NP, Omer SB. Elimination of Nonmedical Immunization Exemptions in California and School-Entry Vaccine Status. Pediatrics. 2019 Jun;143(6). pii: e20183301. doi: 10.1542/peds.2018-3301. Epub 2019 May 21. PubMed Abstract.
  • Chamberlain AT, Limaye RJ, O’Leary ST, Frew PM, Brewer SE, Spina CI, Ellingson MK, Dudley MZ, Orenstein WA, Donnelly MA, Riley LE, Ault KA, Salmon DA, Omer SB. Development and acceptability of a video-based vaccine promotion tutorial for obstetric care providers. Vaccine. 2019 May 1;37(19):2532-2536. doi: 10.1016/j.vaccine.2019.03.005. Epub 2019 Apr 5. PubMed Abstract.
  • Bleser WK, Miranda PY, Salmon DA. Child Influenza Vaccination and Adult Work Loss: Reduced Sick Leave Use Only in Adults With Paid Sick Leave. Am J Prev Med. 2019 Feb;56(2):251-261. doi: 10.1016/j.amepre.2018.09.013. Epub 2018 Dec 17. PubMed Abstract.
  • Ellingson MK, Dudley MZLimaye RJSalmon DA, O’Leary ST, Omer SB. Enhancing uptake of influenza maternal vaccine. Expert Rev Vaccines. 2019 Feb;18(2):191-204. doi: 10.1080/14760584.2019.1562907. Epub 2019 Jan 28. Review. PubMed Abstract.
  • McDonald P, Limaye RJ, Omer SB, Buttenheim AM, Mohanty S, Klein NP, Salmon DA. Exploring California’s new law eliminating personal belief exemptions to childhood vaccines and vaccine decision-making among homeschooling mothers in California. Vaccine. 2019 Jan 29;37(5):742-750. doi: 10.1016/j.vaccine.2018.12.018. Epub 2019 Jan 6. PubMed Abstract.
  • Herman R, McNutt LA, Mehta M, Salmon DA, Bednarczyk RA, Shaw J. Vaccination perspectives among adolescents and their desired role in the decision-making process. Hum Vaccin Immunother. 2019;15(7-8):1752-1759. doi: 10.1080/21645515.2019.1571891. Epub 2019 Mar 14. PubMed Abstract.

2018

  • Bednarczyk RA, Chamberlain A, Mathewson K, Salmon DA, Omer SB. Practice-, Provider-, and Patient-level interventions to improve preventive care: Development of the P3 Model. Prev Med Rep. 2018 Jun 18;11:131-138. doi: 10.1016/j.pmedr.2018.06.009. eCollection 2018 Sep. PubMed Abstract.
  • Talaat KRHalsey NA, Cox AB, Coles CL, Durbin AP, Ramakrishnan A, Bream JH. Rapid changes in serum cytokines and chemokines in response to inactivated influenza vaccination. Influenza Other Respir Viruses. 2018 Mar;12(2):202-210. doi: 10.1111/irv.12509. Epub 2018 Jan 4. PubMed Abstract.

2017

  • Willis ED, Woodward M, Brown E, Popmihajlov Z, Saddier P, Annunziato PW, Halsey NA, Gershon AA. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience. Vaccine. 2017 Dec 19;35(52):7231-7239. doi: 10.1016/j.vaccine.2017.11.013. Epub 2017 Nov 22. Review. PubMed Abstract.
  • Omer SB, Porter RM, Allen K, Salmon DA, Bednarczyk RA. Trends in Kindergarten Rates of Vaccine Exemption and State-Level Policy, 2011-2016. Open Forum Infect Dis. 2017 Nov 15;5(2):ofx244. doi: 10.1093/ofid/ofx244. eCollection 2018 Feb. PubMed Abstract.
  • Halsey NA, Proveaux T. Value of an in-depth analysis of unpublished data on the safety of influenza vaccines in pregnant women. Vaccine. 2017 Oct 27;35(45):6154-6159. doi: 10.1016/j.vaccine.2017.09.049. Epub 2017 Sep 27. PubMed Abstract.
  • Omer SB, Amin AB, Limaye RJ. Communicating About Vaccines in a Fact-Resistant World. JAMA Pediatr. 2017 Oct 1;171(10):929-930. doi: 10.1001/jamapediatrics.2017.2219. PubMed Abstract.
  • Shaw J, Halsey NA, Weinberg A, Scott Schmid D, George KS, Weldon WC, Jordan M, Bryant PW, LaRussa PS, Bradshaw DY, Harrington T, Gershon A. Arm Paralysis After Routine Childhood Vaccinations: Application of Advanced Molecular Methods to the Causality Assessment of an Adverse Event After Immunization. J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e161-e164. doi: 10.1093/jpids/piw084. PubMed Abstract.
  • Gessner BD, Halsey N. Dengue vaccine safety signal: Immune enhancement, waning immunity, or chance occurrence? Vaccine. 2017 Jun 14;35(27):3452-3456. doi: 10.1016/j.vaccine.2017.05.003. Epub 2017 May 18. PubMed Abstract.
  • Bednarczyk RA, Frew PM, Salmon DA, Whitney E, Omer SB. ReadyVax: A new mobile vaccine information app. Hum Vaccin Immunother. 2017 May 4;13(5):1149-1154. doi: 10.1080/21645515.2016.1263779. Epub 2017 Jan 6. PubMed Abstract.
  • Halsey NA. Reflections of a Vaccinologist: Lessons Learned About What We Can Do to Improve Trust in Vaccines and Vaccine Programsa. J Pediatric Infect Dis Soc. 2017 Mar 1;6(1):3-8. doi: 10.1093/jpids/piv077. PubMed Abstract.

2016

  • Proveaux T, Lambach P, Ortiz JR, Hombach J, Halsey NA. Review of prescribing information for influenza vaccines for pregnant and lactating women. Vaccine. 2016 Oct 26;34(45):5406-5409. doi: 10.1016/j.vaccine.2016.08.042. Epub 2016 Aug 29. Review. PubMed Abstract.
  • Talaat KR, Ellis RD, Hurd J, Hentrich A, Gabriel E, Hynes NA, Rausch KM, Zhu D, Muratova O, Herrera R, Anderson C, Jones D, Aebig J, Brockley S, MacDonald NJ, Wang X, Fay MP, Healy SA, Durbin AP, Narum DL, Wu Y, Duffy PE. Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults. PLoS One. 2016 Oct 17;11(10):e0163144. doi: 10.1371/journal.pone.0163144. eCollection 2016. PubMed Abstract.
  • Vadaparampil ST, Malo TL, Sutton SK, Ali KN, Kahn JA, Casler A, Salmon D, Walkosz B, Roetzheim RG, Zimet GD, Giuliano AR. Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11- to 12-Year-Old Males. Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1435-1446. Epub 2016 Aug 2. PubMed Abstract.
  • Dreskin SC, Halsey NA, Kelso JM, Wood RA, Hummell DS, Edwards KM, Caubet JC, Engler RJ, Gold MS, Ponvert C, Demoly P, Sanchez-Borges M, Muraro A, Li JT, Rottem M, Rosenwasser LJ. International Consensus (ICON): allergic reactions to vaccines. World Allergy Organ J. 2016 Sep 16;9(1):32. doi: 10.1186/s40413-016-0120-5. eCollection 2016. PubMed Abstract.
  • Phadke VK, Bednarczyk RA, Salmon DA, Omer SB. Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis. JAMA. 2016 Mar 15;315(11):1149-58. doi: 10.1001/jama.2016.1353. Review. Erratum in: JAMA. 2016 May 17;315(19):2125. JAMA. 2016 May 17;315 (19):2125. PubMed Abstract.

2015

  • Halsey NATalaat KR, Greenbaum A, Mensah E, Dudley MZ, Proveaux T, Salmon DA. The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper. Vaccine. 2015 Dec 30;33 Suppl 5:F1-F67. doi: 10.1016/j.vaccine.2015.10.080. Review. PubMed Abstract.
  • Salmon DADudley MZ, Glanz JM, Omer SB. Vaccine Hesitancy: Causes, Consequences, and a Call to Action. Am J Prev Med. 2015 Dec;49(6 Suppl 4):S391-8. doi: 10.1016/j.amepre.2015.06.009. Epub 2015 Aug 31. PubMed Abstract.
  • Salmon DADudley MZ, Glanz JM, Omer SB. Vaccine hesitancy: Causes, consequences, and a call to action. Vaccine. 2015 Nov 27;33 Suppl 4:D66-71. doi: 10.1016/j.vaccine.2015.09.035. PubMed Abstract.
  • Vannice KS, Keita M, Sow SO, Durbin AP, Omer SB, Moulton LH, Yaméogo TM, Zuber PL, Onwuchekwa U, Sacko M, Diomandé FV, Halsey NA. Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali. Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S493-500. doi: 10.1093/cid/civ497. PubMed Abstract.

2014

  • Atwell JE, Salmon DA. Pertussis resurgence and vaccine uptake: implications for reducing vaccine hesitancy. Pediatrics. 2014 Sep;134(3):602-4. doi: 10.1542/peds.2014-1883. PubMed Abstract.
  • Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, Juvekar S, Muliyil J, Arya A, Shaikh H, Abraham V, Vrati S, Proschan M, Kohberger R, Thiry G, Glass R, Greenberg HB, Curlin G, Mohan K, Harshavardhan GV, Prasad S, Rao TS, Boslego J, Bhan MK; India Rotavirus Vaccine Group. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life. Vaccine. 2014 Aug 11;32 Suppl 1:A110-6. doi: 10.1016/j.vaccine.2014.04.079. PubMed Abstract.
  • Hofstetter AM, Jakob K, Klein NP, Dekker CL, Edwards KM, Halsey NA, Baxter R, Williams SE, Graham PL 3rd, LaRussa P. Live vaccine use and safety in DiGeorge syndrome. Pediatrics. 2014 Apr;133(4):e946-54. doi: 10.1542/peds.2013-0831. Epub 2014 Mar 31. PubMed Abstract.
  • Vadaparampil ST, Malo TL, Kahn JA, Salmon DA, Lee JH, Quinn GP, Roetzheim RG, Bruder KL, Proveaux TM, Zhao X, Halsey NA, Giuliano AR. Physicians’ human papillomavirus vaccine recommendations, 2009 and 2011. Am J Prev Med. 2014 Jan;46(1):80-4. doi: 10.1016/j.amepre.2013.07.009. PubMed Abstract.

2013

  • Halsey NA, Griffioen M, Dreskin SC, Dekker CL, Wood R, Sharma D, Jones JF, LaRussa PS, Garner J, Berger M, Proveaux T, Vellozzi C; Hypersensitivity Working Group of the Clinical Immunization Safety Assessment Network, Broder K, Setse R, Pahud B, Hrncir D, Choi H, Sparks R, Williams SE, Engler RJ, Gidudu J, Baxter R, Klein N, Edwards K, Cano M, Kelso JM. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS. Vaccine. 2013 Dec 9;31(51):6107-12. doi: 10.1016/j.vaccine.2013.09.066. Epub 2013 Oct 8. PubMed Abstract.
  • Asturias EJ, Contreras-Roldan IL, Ram M, Garcia-Melgar AJ, Morales-Oquendo V, Hartman K, Rauscher M, Moulton LHHalsey NA. Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children. Vaccine. 2013 Dec 2;31(49):5909-14. doi: 10.1016/j.vaccine.2013.09.015. Epub 2013 Sep 19. PubMed Abstract.
  • Tozzi AE, Asturias EJ, Balakrishnan MR, Halsey NA, Law B, Zuber PL. Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use. Vaccine. 2013 Oct 17;31(44):5041-6. doi: 10.1016/j.vaccine.2013.08.087. Epub 2013 Sep 8. PubMed Abstract.
  • Mergler MJ, Omer SB, Pan WK, Navar-Boggan AM, Orenstein W, Marcuse EK, Taylor J, DeHart MP, Carter TC, Damico A, Halsey NSalmon DA. Association of vaccine-related attitudes and beliefs between parents and health care providers. Vaccine. 2013 Sep 23;31(41):4591-5. doi: 10.1016/j.vaccine.2013.07.039. Epub 2013 Jul 27. PubMed Abstract.
  • Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Gutierrez-Gimeno MV, Heijbel H, Hughes H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Gimenez-Sanchez F, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H; Global H1N1 GBS Consortium. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine. 2013 Sep 13;31(40):4448-58. doi: 10.1016/j.vaccine.2013.06.032. Epub 2013 Jun 14. PubMed Abstract.
  • Williams SE, Edwards KM, Baxter RP, LaRussa PS, Halsey NA, Dekker CL, Vellozzi C, Marchant CD, Donofrio PD, Reimschisel TE, Berger M, Gidudu JF, Klein NP. Comprehensive assessment of serious adverse events following immunization by health care providers. J Pediatr. 2013 Jun;162(6):1276-81, 1281.e1. doi: 10.1016/j.jpeds.2013.01.028. Epub 2013 Feb 26. PubMed Abstract.
  • Grant L, Watt J, Moulton L, Weatherholtz R, Reid R, Santosham M, O’Brien K. Lack of nonspecific protection against all-cause nonrotavirus gastroenteritis by vaccination with orally administered rotavirus vaccine. J Pediatr Gastroenterol Nutr. 2013 Jun;56(6):635-40. doi: 10.1097/MPG.0b013e318287c5cc. PubMed Abstract.
  • Mergler MJ, Omer SB, Pan WK, Navar-Boggan AM, Orenstein W, Marcuse EK, Taylor J, deHart MP, Carter TC, Damico A, Halsey NSalmon DA. Are Recent Medical Graduates More Skeptical of Vaccines? Vaccines (Basel). 2013 Apr 29;1(2):154-66. doi: 10.3390/vaccines1020154. PubMed Abstract.
  • Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N; H1N1 GBS Meta-Analysis Working Group. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8. Epub 2013 Mar 13. PubMed Abstract.
  • Durbin AP, Kirkpatrick BD, Pierce KK, Elwood D, Larsson CJ, Lindow JC, Tibery C, Sabundayo BP, Shaffer D, Talaat KR, Hynes NA, Wanionek K, Carmolli MP, Luke CJ, Murphy BR, Subbarao K, Whitehead SS. A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial. J Infect Dis. 2013 Mar 15;207(6):957-65. doi: 10.1093/infdis/jis936. Epub 2013 Jan 17. PubMed Abstract.
  • Pahud BA, Williams SE, Dekker CL, Halsey N, Larussa P, Baxter RP, Klein NP, Marchant CD, Sparks RC, Jakob K, Aukes L, Swope S, Barnett E, Lewis P, Berger M, Dreskin SC, Donofrio PD, Sejvar JJ, Slade BA, Gidudu J, Vellozzi C, Edwards KM. Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination. Pediatr Infect Dis J. 2013 Feb;32(2):163-8. doi: 10.1097/INF.0b013e318271b90a. PubMed Abstract.

2012

  • Talaat KR, Karron RA, Liang PH, McMahon BA, Luke CJ, Thumar B, Chen GL, Min JY, Lamirande EW, Jin H, Coelingh KL, Kemble GW, Subbarao K. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults. Influenza Other Respir Viruses. 2013 Jan;7(1):66-73. doi: 10.1111/j.1750-2659.2012.00350.x. Epub 2012 Mar 14. PubMed Abstract.
  • Rowhani-Rahbar A, Klein NP, Dekker CL, Edwards KM, Marchant CD, Vellozzi C, Fireman B, Sejvar JJ, Halsey NA, Baxter R; Risk Interval Working Group of the Clinical Immunization Safety Assessment Network. Biologically plausible and evidence-based risk intervals in immunization safety research. Vaccine. 2012 Dec 17;31(1):271-7. doi: 10.1016/j.vaccine.2012.07.024. Epub 2012 Jul 24. Review. PubMed Abstract.
  • Salmon D, Yih WK, Lee G, Rosofsky R, Brown J, Vannice K, Tokars J, Roddy J, Ball R, Gellin B, Lurie N, Koh H, Platt R, Lieu T; PRISM Program Group. Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance. Health Aff (Millwood). 2012 Nov;31(11):2518-27. doi: 10.1377/hlthaff.2012.0104. PubMed Abstract.
  • Halsey NA, Edwards KM, Dekker CL, Klein NP, Baxter R, Larussa P, Marchant C, Slade B, Vellozzi C; Causality Working Group of the Clinical Immunization Safety Assessment network. Algorithm to assess causality after individual adverse events following immunizations. Vaccine. 2012 Aug 24;30(39):5791-8. Epub 2012 Apr 14. PubMed Abstract.
  • Sullender W, Fowler K, Krishnan A, Gupta V, Moulton LH, Lafond K, Widdowson MA, Lal RB, Broor S. Design and initiation of a study to assess the direct and indirect effects of influenza vaccine given to children in rural India. Vaccine. 2012 Jul 27;30(35):5235-9. doi: 10.1016/j.vaccine.2012.06.002. Epub 2012 Jun 16. PubMed Abstract.
  • Yih WK, Lee GM, Lieu TA, Ball R, Kulldorff M, Rett M, Wahl PM, McMahill-Walraven CN, Platt R, Salmon DA. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010. Am J Epidemiol. 2012 Jun 1;175(11):1120-8. doi: 10.1093/aje/kws197. Epub 2012 May 11. PubMed Abstract.
  • Scott JR, Hanage WP, Lipsitch M, Millar EV, Moulton LH, Hinds J, Reid R, Santosham M, O’Brien KL. Pneumococcal sequence type replacement among American Indian children: a comparison of pre- and routine-PCV7 eras. Vaccine. 2012 Mar 16;30(13):2376-81. doi: 10.1016/j.vaccine.2011.11.004. Epub 2011 Nov 15. PubMed Abstract.
  • Grant LR, Watt JP, Weatherholtz RC, Moulton LH, Reid R, Santosham M, O’Brien KL. Efficacy of a pentavalent human-bovine reassortant rotavirus vaccine against rotavirus gastroenteritis among American Indian children. Pediatr Infect Dis J. 2012 Feb;31(2):184-8. doi: 10.1097/INF.0b013e3182435afe. PubMed Abstract.
  • Jones AM, Omer SB, Bednarczyk RA, Halsey NAMoulton LHSalmon DA. Parents’ source of vaccine information and impact on vaccine attitudes, beliefs, and nonmedical exemptions. Adv Prev Med. 2012;2012:932741. doi: 10.1155/2012/932741. Epub 2012 Oct 2. PubMed Abstract.

2011

  • Williams SE, Pahud BA, Vellozzi C, Donofrio PD, Dekker CL, Halsey N, Klein NP, Baxter RP, Marchant CD, Larussa PS, Barnett ED, Tokars JI, McGeeney BE, Sparks RC, Aukes LL, Jakob K, Coronel S, Sejvar JJ, Slade BA, Edwards KM. Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination. Vaccine. 2011 Oct 26;29(46):8302-8. doi: 10.1016/j.vaccine.2011.08.093. Epub 2011 Sep 3. PubMed Abstract.
  • Williams SE, Klein NP, Halsey N, Dekker CL, Baxter RP, Marchant CD, LaRussa PS, Sparks RC, Tokars JI, Pahud BA, Aukes L, Jakob K, Coronel S, Choi H, Slade BA, Edwards KM. Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009. Vaccine. 2011 Sep 16;29(40):6920-7. doi: 10.1016/j.vaccine.2011.07.044. Epub 2011 Jul 27. Review. PubMed Abstract.
  • Salmon DA, Akhtar A, Mergler MJ, Vannice KS, Izurieta H, Ball R, Lee GM, Vellozzi C, Garman P, Cunningham F, Gellin B, Koh H, Lurie N; H1N1 Working Group of Federal Immunization Safety Task Force. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Pediatrics. 2011 May;127 Suppl 1:S78-86. doi: 10.1542/peds.2010-1722L. Epub 2011 Apr 18. Review. PubMed Abstract.
  • Vannice KS, Salmon DA, Shui I, Omer SB, Kissner J, Edwards KM, Sparks R, Dekker CL, Klein NP, Gust DA. Attitudes and beliefs of parents concerned about vaccines: impact of timing of immunization information. Pediatrics. 2011 May;127 Suppl 1:S120-6. doi: 10.1542/peds.2010-1722R. Epub 2011 Apr 18. PubMed Abstract.
  • Salmon DA, Pavia A, Gellin B. Editors’ introduction: Vaccine safety throughout the product life cycle. Pediatrics. 2011 May;127 Suppl 1:S1-4. doi: 10.1542/peds.2010-1722U. Epub 2011 Apr 18. PubMed Abstract.
  • LaRussa PS, Edwards KM, Dekker CL, Klein NP, Halsey NA, Marchant C, Baxter R, Engler RJ, Kissner J, Slade BA. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network. Pediatrics. 2011 May;127 Suppl 1:S65-73. doi: 10.1542/peds.2010-1722J. Epub 2011 Apr 18. PubMed Abstract.
  • Hussain H, Omer SB, Manganello JA, Kromm EE, Carter TC, Kan L, Stokley S, Halsey NASalmon DA. Immunization safety in US print media, 1995-2005. Pediatrics. 2011 May;127 Suppl 1:S100-6. doi: 10.1542/peds.2010-1722O. Epub 2011 Apr 18. PubMed Abstract.
  • Talaat KR, Karron RA, Luke CJ, Thumar B, McMahon BA, Chen GL, Lamirande EW, Jin H, Coelingh KL, Kemble G, Subbarao K. An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults. Vaccine. 2011 Apr 12;29(17):3144-8. doi: 10.1016/j.vaccine.2011.02.043. Epub 2011 Mar 4. PubMed Abstract.
  • Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M; Brighton Collaboration GBS Working Group. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011 Jan 10;29(3):599-612. doi: 10.1016/j.vaccine.2010.06.003. Epub 2010 Jun 18. Review. PubMed Abstract.
  • Shen AK, Spinner JR, Salmon DA, Gellin BG. Strengthening the U.S. vaccine and immunization enterprise: the role of the National Vaccine Advisory Committee. Public Health Rep. 2011 Jan-Feb;126(1):4-8. PubMed Abstract.

2010

  • Smith PJ, Humiston SG, Parnell T, Vannice KS, Salmon DA. The association between intentional delay of vaccine administration and timely childhood vaccination coverage. Public Health Rep. 2010 Jul-Aug;125(4):534-41. PubMed Abstract.
  • Black S, Mulholland K, Halsey NA. Developing sustainable funding for vaccine safety infrastructure. Vaccine. 2010 Feb 3;28(5):1133-4. doi: 10.1016/j.vaccine.2009.11.034. Epub 2009 Nov 27. Review. PubMed Abstract.

2009

  • Black S, Eskola J, Siegrist CA, Halsey N, MacDonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, Vannice K, Izurieta HS, Akhtar A, Gold M, Oselka G, Zuber P, Pfeifer D, Vellozzi C. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet. 2009 Dec 19;374(9707):2115-2122. doi: 10.1016/S0140-6736(09)61877-8. Epub 2009 Oct 31. Erratum in: Lancet. 2010 Jan 30;375(9712):376. PubMed Abstract.
  • Tamma PD, Ault KA, del Rio C, Steinhoff MC, Halsey NA, Omer SB. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol. 2009 Dec;201(6):547-52. doi: 10.1016/j.ajog.2009.09.034. Epub 2009 Oct 21. Review. PubMed Abstract.
  • Bogdanovic J, Halsey NA, Wood RA, Hamilton RG. Bovine and porcine gelatin sensitivity in children sensitized to milk and meat. J Allergy Clin Immunol. 2009 Nov;124(5):1108-10. doi: 10.1016/j.jaci.2009.06.021. Epub 2009 Aug 8. PubMed Abstract.
  • Durbin AP, Setse R, Omer SB, Palmer JG, Spaeder JA, Baker J, Lessans F, Halsey NA. Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system. Vaccine. 2009 Oct 19;27(44):6143-7. doi: 10.1016/j.vaccine.2009.08.024. Epub 2009 Aug 25. PubMed Abstract.
  • Karron RA, Talaat K, Luke C, Callahan K, Thumar B, Dilorenzo S, McAuliffe J, Schappell E, Suguitan A, Mills K, Chen G, Lamirande E, Coelingh K, Jin H, Murphy BR, Kemble G, Subbarao K. Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine. 2009 Aug 6;27(36):4953-60. doi: 10.1016/j.vaccine.2009.05.099. Epub 2009 Jun 21. PubMed Abstract.
  • Salmon DA, Smith PJ, Pan WK, Navar AM, Omer SB, Halsey NA. Disparities in preschool immunization coverage associated with maternal age. Hum Vaccin. 2009 Aug;5(8):557-61. Epub 2009 Aug 14. PubMed Abstract.
  • Talaat KR, Karron RA, Callahan KA, Luke CJ, DiLorenzo SC, Chen GL, Lamirande EW, Jin H, Coelingh KL, Murphy BR, Kemble G, Subbarao K. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine. 2009 Jun 8;27(28):3744-53. doi: 10.1016/j.vaccine.2009.03.082. Epub 2009 Apr 17. PubMed Abstract.
  • Asturias EJ, Mayorga C, Caffaro C, Ramirez P, Ram M, Verstraeten T, Clemens R, Halsey NA. Differences in the immune response to hepatitis B and Haemophilus influenzae type b vaccines in Guatemalan infants by ethnic group and nutritional status. Vaccine. 2009 Jun 2;27(27):3650-4. doi: 10.1016/j.vaccine.2009.03.035. Epub 2009 Apr 7. PubMed Abstract.
  • Salmon DA, Sotir MJ, Pan WK, Berg JL, Omer SB, Stokley S, Hopfensperger DJ, Davis JP, Halsey NA. Parental vaccine refusal in Wisconsin: a case-control study. WMJ. 2009 Feb;108(1):17-23. PubMed Abstract.

2008

  • Noazin S, Modabber F, Khamesipour A, Smith PG, Moulton LH, Nasseri K, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Kieny MP, Tanner M. First generation leishmaniasis vaccines: a review of field efficacy trials. Vaccine. 2008 Dec 9;26(52):6759-67. doi: 10.1016/j.vaccine.2008.09.085. Epub 2008 Oct 23. Review. PubMed Abstract.
  • Kohl KS, Magnus M, Ball R, Halsey N, Shadomy S, Farley TA. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization. Vaccine. 2008 Nov 25;26(50):6349-60. doi: 10.1016/j.vaccine.2008.09.002. Epub 2008 Sep 19. PubMed Abstract.
  • Launay O, Grabar S, Gordien E, Desaint C, Jegou D, Abad S, Girard PM, Bélarbi L, Guérin C, Dimet J, Williams V, Krivine A, Salmon D, Lortholary O, Rey D; HEPAVAC Study Group1. Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study. J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):272-5. doi: 10.1097/QAI.0b013e318183a9c0. PubMed Abstract.
  • Halsey NA. The human papillomavirus vaccine and risk of anaphylaxis. CMAJ. 2008 Sep 9;179(6):509-10. doi: 10.1503/cmaj.081133. Epub 2008 Sep 1. Erratum in: CMAJ. 2008 Sep 23;179(7):678. PubMed Abstract.
  • Wood RA, Berger M, Dreskin SC, Setse R, Engler RJ, Dekker CL, Halsey NA; Hypersensitivity Working Group of the Clinical Immunization Safety Assessment (CISA) Network. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics. 2008 Sep;122(3):e771-7. doi: 10.1542/peds.2008-1002. PubMed Abstract.
  • Salmon DA, Pan WK, Omer SB, Navar AM, Orenstein W, Marcuse EK, Taylor J, deHart MP, Stokley S, Carter T, Halsey NA. Vaccine knowledge and practices of primary care providers of exempt vs. vaccinated children. Hum Vaccin. 2008 Jul-Aug;4(4):286-91. Epub 2008 Feb 19. PubMed Abstract.

2007

  • Vernick JS, Rutkow L, Salmon DA. Availability of litigation as a public health tool for firearm injury prevention: comparison of guns, vaccines, and motor vehicles. Am J Public Health. 2007 Nov;97(11):1991-7. Epub 2007 Sep 27. PubMed Abstract.
  • Návar AM, Halsey NA, Carter TC, Montgomery MP, Salmon DA. Prenatal immunization education the pediatric prenatal visit and routine obstetric care. Am J Prev Med. 2007 Sep;33(3):211-3. PubMed Abstract.
  • Launay O, Durier C, Desaint C, Silbermann B, Jackson A, Pialoux G, Bonnet B, Poizot-Martin I, Gonzalez-Canali G, Cuzin L, Figuereido S, Surenaud M, Ben Hamouda N, Gahery H, Choppin J, Salmon D, Guérin C, Bourgault Villada I, Guillet JG; ANRS VAC16 Study Group. Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial. PLoS One. 2007 Aug 22;2(8):e725. PubMed Abstract.
  • Wood RA, Setse R, Halsey N; Clinical Immunization Safety Assessment (CISA) Network Hypersensitivity Working Group. Irritant skin test reactions to common vaccines. J Allergy Clin Immunol. 2007 Aug;120(2):478-81. Epub 2007 Jun 4. PubMed Abstract.

2006

  • Halsey NA. Measles in developing countries. BMJ. 2006 Dec 16;333(7581):1234. PubMed Abstract.
  • Omer SB, Pan WK, Halsey NA, Stokley S, Moulton LH, Navar AM, Pierce M, Salmon DA. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. JAMA. 2006 Oct 11;296(14):1757-63. PubMed Abstract.
  • Linkins RW, Salmon DA, Omer SB, Pan WK, Stokley S, Halsey NA. Support for immunization registries among parents of vaccinated and unvaccinated school-aged children: a case control study. BMC Public Health. 2006 Sep 22;6:236. PubMed Abstract.
  • Khan AJ, Gebreselassie H, Asturias EJ, Agboatwalla M, Teklehaimanot R, Luby SP, Beyene B, Chezzi C, Asghar H, Moatter T, Torres OR, Kew O, Winkelstein J, Halsey NA. No evidence for prolonged excretion of polioviruses in persons with residual paralytic poliomyelitis in Ethiopia, Pakistan and Guatemala. Biologicals. 2006 Jun;34(2):113-6. Epub 2006 May 8. Erratum in: Biologicals. 2007 Mar;35(1):73. Bayene, Berhane [corrected to Beyene, Berhane]. PubMed Abstract.
  • Modlin JF, Halsey NA. Excretion of oral poliovirus vaccine strains: effect of vaccination schedule. J Infect Dis. 2006 Jun 1;193(11):1614-5. PubMed Abstract.
  • Durier C, Launay O, Meiffrédy V, Saïdi Y, Salmon D, Lévy Y, Guillet JG, Pialoux G, Aboulker JP. Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults. AIDS. 2006 Apr 24;20(7):1039-49. PubMed Abstract.
  • Salmon DA, Teret SP, MacIntyre CR, Salisbury D, Burgess MA, Halsey NA. Compulsory vaccination and conscientious or philosophical exemptions: past, present, and future. Lancet. 2006 Feb 4;367(9508):436-42. Review. PubMed Abstract.
  • Salmon DA, Smith PJ, Navar AM, Pan WK, Omer SB, Singleton JA, Halsey NA. Measuring immunization coverage among preschool children: past, present, and future opportunities. Epidemiol Rev. 2006;28:27-40. Epub 2006 Jun 1. Review. PubMed Abstract.

2005

  • Moulton LH, Rahmathullah L, Halsey NA, Thulasiraj RD, Katz J, Tielsch JM. Evaluation of non-specific effects of infant immunizations on early infant mortality in a southern Indian population. Trop Med Int Health. 2005 Oct;10(10):947-55. PubMed Abstract.
  • Salmon DA, Sapsin JW, Teret S, Jacobs RF, Thompson JW, Ryan K, Halsey NA. Public health and the politics of school immunization requirements. Am J Public Health. 2005 May;95(5):778-83. Review. PubMed Abstract.
  • Salmon DAMoulton LH, Omer SB, DeHart MP, Stokley S, Halsey NA. Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study. Arch Pediatr Adolesc Med. 2005 May;159(5):470-6. PubMed Abstract.
  • MacIntyre CR, Kelly H, Jolley D, Butzkueven H, Salmon DHalsey NMoulton LH. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology. 2005 Apr 12;64(7):1317; author reply 1318. PubMed Abstract.
  • Salmon DA, Omer SB, Moulton LH, Stokley S, Dehart MP, Lett S, Norman B, Teret S, Halsey NA. Exemptions to school immunization requirements: the role of school-level requirements, policies, and procedures. Am J Public Health. 2005 Mar;95(3):436-40. Erratum in: Am J Public Health. 2005 Apr;95(4):551. PubMed Abstract.

2004

  • Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, Ward BJ, West DJ. Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):825-40. Review. PubMed Abstract.
  • Kalies H, Verstraeten T, Grote V, Meyer N, Siedler A, Schmitt HJ, Breuer T, Moulton LH, von Kries R; Erhebungseinheit für seltene pädiatrische Erkrankungen in Deutschland Study Group. Four and one-half-year follow-up of the effectiveness of diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b and diphtheria-tetanus toxoids-acellular pertussis-inactivated poliovirus/H. influenzae type b combination vaccines in Germany. Pediatr Infect Dis J. 2004 Oct;23(10):944-50. PubMed Abstract.
  • Salmon DAMoulton LHHalsey NA. Enhancing public confidence in vaccines through independent oversight of postlicensure vaccine safety. Am J Public Health. 2004 Jun;94(6):947-50. PubMed Abstract.
  • Salmon DAMoulton LH, Omer SB, Chace LM, Klassen A, Talebian P, Halsey NA. Knowledge, attitudes, and beliefs of school nurses and personnel and associations with nonmedical immunization exemptions. Pediatrics. 2004 Jun;113(6):e552-9. PubMed Abstract.
  • Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA. 2004 May 5;291(17):2086-91. PubMed Abstract.
  • Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004 May 1;189 Suppl 1:S4-16. Review. PubMed Abstract.
  • Rothstein E, Kohl KS, Ball L, Halperin SA, Halsey N, Hammer SJ, Heath PT, Hennig R, Kleppinger C, Labadie J, Varricchio F, Vermeer P, Walop W; Brighton Collaboration Local Reaction Working Group. Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine. 2004 Jan 26;22(5-6):575-85. Review. PubMed Abstract.
  • Bonhoeffer J, Menkes J, Gold MS, de Souza-Brito G, Fisher MC, Halsey N, Vermeer P; Brighton Collaboration Seizure Working Group. Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine. 2004 Jan 26;22(5-6):557-62. Review. PubMed Abstract.
  • Halsey NA, Pinto J, Espinosa-Rosales F, Faure-Fontenla MA, da Silva E, Khan AJ, Webster AD, Minor P, Dunn G, Asturias E, Hussain H, Pallansch MA, Kew OM, Winkelstein J, Sutter R; Polio Project Team. Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. Bull World Health Organ. 2004 Jan;82(1):3-8. PubMed Abstract.

2003

  • Asturias EJ, Soto M, Menendez R, Ramirez PL, Recinos F, Gordillo R, Holt E, Halsey NA. Meningitis and pneumonia in Guatemalan children: the importance of Haemophilus influenzae type b and Streptococcus pneumoniae. Rev Panam Salud Publica. 2003 Dec;14(6):377-84. PubMed Abstract.
  • O’Brien KL, Moulton LH, Reid R, Weatherholtz R, Oski J, Brown L, Kumar G, Parkinson A, Hu D, Hackell J, Chang I, Kohberger R, Siber G, Santosham M. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet. 2003 Aug 2;362(9381):355-61. PubMed Abstract.
  • Bartlett J, Borio L, Radonovich L, Mair JS, O’Toole T, Mair M, Halsey N, Grow R, Inglesby TV. Smallpox vaccination in 20key information for clinicians. Clin Infect Dis. 2003 Apr 1;36(7):883-902. Epub 2003 Mar 18. PubMed Abstract.
  • Halsey NA. Commentary: poliomyelitis and unnecessary injections. Int J Epidemiol. 2003 Apr;32(2):278-9. PubMed Abstract.
  • Moss WJ, Clements CJ, Halsey NA. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ. 2003;81(1):61-70. Epub 2003 Mar 11. Review. PubMed Abstract.
  • Halsey N, Rose N. Questions and answers about autoimmunity and the smallpox vaccine. Isr Med Assoc J. 2003 Jan;5(1):40-1. PubMed Abstract.
  • Furth SL, Hogg RJ, Tarver J, Moulton LH, Chan C, Fivush BA; Southwest Pediatric Nephrology Study Group. Varicella vaccination in children with chronic renal failure. A report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol. 2003 Jan;18(1):33-8. Epub 2002 Nov 22. PubMed Abstract.

2002

  • Ball R, Halsey N, Braun MM, Moulton LH, Gale AD, Rammohan K, Wiznitzer M, Johnson R, Salive ME; VAERS Working Group. Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the vaccine: Adverse Event Reporting System. J Clin Epidemiol. 2002 Aug;55(8):819-24. PubMed Abstract.
  • Halsey NA. The science of evaluation of adverse events associated with vaccination. Semin Pediatr Infect Dis. 2002 Jul;13(3):205-14. Review. PubMed Abstract.
  • Halsey NA. The need for immunoglobulin for travelers who receive hepatitis A vaccine. Pediatr Infect Dis J. 2002 Jun;21(6):576-7. PubMed Abstract.
  • Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ; Anthrax Vaccine Export Committee. Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):189-202. Review. PubMed Abstract.
  • Halsey NA. Anthrax vaccine and causality assessment from individual case reports. Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):185-7; discussion 203-4. PubMed Abstract.
  • Leitch R, Halsey N, Hyman SL. MMR–Separate administration-has it been done? Pediatrics. 2002 Jan;109(1):172. PubMed Abstract.

2001

  • Halsey NA. Combination vaccines: defining and addressing current safety concerns. Clin Infect Dis. 2001 Dec 15;33 Suppl 4:S312-8. Review. PubMed Abstract.
  • Halsey NA. Safety of combination vaccines: perception versus reality. Pediatr Infect Dis J. 2001 Nov;20(11 Suppl):S40-4. Review. PubMed Abstract.
  • Moulton LH, O’Brien KL, Kohberger R, Chang I, Reid R, Weatherholtz R, Hackell JG, Siber GR, Santosham M. Design of a group-randomized Streptococcus pneumoniae vaccine trial. Control Clin Trials. 2001 Aug;22(4):438-52. PubMed Abstract.
  • Halsey NA, Goldman L. Balancing risks and benefits: Primum non nocere is too simplistic. Pediatrics. 2001 Aug;108(2):466-7. PubMed Abstract.
  • Sikand VK, Halsey N, Krause PJ, Sood SK, Geller R, Van Hoecke C, Buscarino C, Parenti D; Pediatric Lyme Vaccine Study Group. Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial. Pediatrics. 2001 Jul;108(1):123-8. PubMed Abstract.
  • Halsey NA, Hyman SL; Conference Writing Panel. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000. Pediatrics. 2001 May;107(5):E84. Review. PubMed Abstract.

2000

  • Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA. 2000 Dec 27;284(24):3145-50. PubMed Abstract.
  • Moulton LH, Chung S, Croll J, Reid R, Weatherholtz RC, Santosham M. Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population. Int J Epidemiol. 2000 Aug;29(4):753-6. PubMed Abstract.
  • Qureshi H, Gessner BD, Leboulleux D, Hasan H, Alam SE, Moulton LH. The incidence of vaccine preventable influenza-like illness and medication use among Pakistani pilgrims to the Haj in Saudi Arabia. Vaccine. 2000 Jul 1;18(26):2956-62. PubMed Abstract.

1999

  • Halsey NA. Limiting infant exposure to thimerosal in vaccines and other sources of mercury. JAMA. 1999 Nov 10;282(18):1763-6. PubMed Abstract.
  • Salmon DA, Haber M, Gangarosa EJ, Phillips L, Smith NJ, Chen RT. Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA. 1999 Jul 7;282(1):47-53. Erratum in: JAMA 2000 May 3;283(17):2241. PubMed Abstract.
  • Childhood immunizations and type 1 diabetes: summary of an Institute for Vaccine Safety Workshop. The Institute for Vaccine Safety Diabetes Workshop Panel. Pediatr Infect Dis J. 1999 Mar;18(3):217-22. Review. PubMed Abstract.
  • Halsey NA, Duclos P, Van Damme P, Margolis H. Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board. Pediatr Infect Dis J. 1999 Jan;18(1):23-4. Review. PubMed Abstract.

Contents